Email Alert RSS
Volume 9 Issue 3
. 
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2018  >  9(3): 271-276
Qian LI, Li-ping JIN, Xue-xun ZHOU. A Survey of Biobank Business Planning in China[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(3): 271-276. doi: 10.3969/j.issn.1674-9081.2018.03.015
Citation: Qian LI, Li-ping JIN, Xue-xun ZHOU. A Survey of Biobank Business Planning in China[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(3): 271-276. doi: 10.3969/j.issn.1674-9081.2018.03.015
shu

A Survey of Biobank Business Planning in China

doi: 10.3969/j.issn.1674-9081.2018.03.015
  • 1.

    Department of Biobank, Translational Medicine Research Centre, Shanghai First Maternity and Infant Hospital, Tongji University, Shanghai 200040, China

  • 2.

    eBiobank' BioSpecimen Science Interest Group, Shanghai 200040, China

  • 3.

    Shanghai Avantech Bioscience Co., Ltd., Shanghai 200040, China

More Information
  • Corresponding author: JIN Li-ping Tel: 021-20261255, E-mail: jinliping@51mch.com; ZHOU Xue-xun Tel: 021-38763568, E-mail: zhou@avantech.cn
  • Received Date: 2018-02-22
  • Publish Date: 2018-05-30
    Abstract
  •   Objective   This study aimed to gauge the current state of biobank business planning in China.   Methods   We conducted a survey among the directors or main participants of 63 biobanks in China. The questionnaire had six categories, including basic information about the biobanks, business planning, utilization, users/customers, marketing/advertising, and cost recovery/performance measures. In this report, we presented a descriptive analysis of the responses in the survey.   Results   In our survey, 96.8% (61/63)of the biobanks belonged to academic institutes or public hospitals; 19.0%(12/63) had business plans; 39.7%(25/63) had a business plan in progress; 41.3%(26/63) had no business plan. In 85.0%(34/40) of the biobanks, the actual utilization rate was less than 20%; and in 97.5%(39/40) of the biobanks, the actual utilization rate of their bio-specimen collections was generally lower than the targeted one. About 88.6%(1084/1223) samples were for internal use but not shared externally.   Conclusions   According to the results of this survey, the situation of biobank business planning in China is not so optimistic. The actual utilization rates of most biobanks were generally lower than their goals, and the main problem was lack of sharing. Cooperation and sharing of domestic biobanks should be further strengthened.
    • FullText(HTML)
  • loading
    • References(15)
  • [1] 陆怡.转化医学与生物样本库现状[J].生命的化学, 2012, 32:287-293. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=smdhx201203018
    [2] 赵晓航, 钱阳明.生物样本库-个体化医学的基础[J].转化医学杂志, 2014, 3:69-74. doi:  10.3978/j.issn.2223-4683.2014.s069
    [3] 郜恒骏.中国生物样本库向标准化迈进[J].中国医药生物技术杂志, 2015, 10:481-483. http://www.cqvip.com/QK/88816X/20156/666843584.html
    [4] 董尔丹, 胡海, 俞文华, 等.生物样本库是生物医学研究的重要基础[J].中国科学:生命科学, 2015, 45:359-370. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgkx-cc201504004
    [5] 郜恒骏, 杜祥, 樊嘉, 等.中国生物样本库理论与实践[M]北京:科学出版社, 2017:6.
    [6] Tamminen S.Bio-objectifying European bodies:standardisa-tion of biobanks in the Biobanking and Biomolecular Resources Research Infrastructure[J].Life Sci Soc Policy, 2015, 11:13. doi:  10.1186/s40504-015-0031-1
    [7] Vaught J.Biobanking comes of age:The Transition to Biospecimen Science[J].Annu Rev Pharmacol Toxicol, 2016, 56:211-228. doi:  10.1146/annurev-pharmtox-010715-103246
    [8] Birch K, Dove ES, Chiappetta M, et al.Biobanks in Oral Health:Promises and Implications of Post-Neoliberal Science and Innovation[J].OMICS, 2016, 20:36-41. doi:  10.1089/omi.2015.0123
    [9] Macheiner T, Huppertz B, Bayer M.Challenges and Driving Forces for Business Plans in Biobanking[J].Biopreserv Biobank, 2017, 15:121-125. doi:  10.1089/bio.2017.0018
    [10] Simeon-Dubach D, Goldring K, Henderson MK.Trends in Biobanking Business Planning:Initial Results of a Survey of Biobankers[J].Biopreserv Biobank, 2017, 5:72-74. http://www.ncbi.nlm.nih.gov/pubmed/27936871
    [11] Ciaburri M, Napolitano M, Bravo E.Business Planning in Biobanking:How to Implement a Tool for Sustainability[J].Biopreserv Biobank, 2017, 15:46-56. doi:  10.1089/bio.2016.0045
    [12] Yuille MM, Feller PI, Georghiou L, et al.Financial Sustainability of Biobanks:From Theory to Practice[J].Biopreserv Biobank, 2017, 15:85-92. doi:  10.1089/bio.2017.29019.mjy
    [13] Tarling TE, Lasser F, Carter C, et al.Business Planning for a Campus-Wide Biobank[J].Biopreserv Biobank, 2017, 15:37-45. doi:  10.1089/bio.2016.0077
    [14] 郭渝成, 郜恒骏, 尹岭, 等.临床生物样本库[M].北京:科学出版社, 2014:1-7.
    [15] 王剑萍, 蔡美玉, 孙孟红, 等.上海市公立医院生物样本库的现状分析[J].中华医学科研管理杂志, 2016, 29:C2-C4. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyxkyglzz201605022
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (384) PDF downloads(442) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return